BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
 | 
Jun 10, 2013
 |  BC Week In Review  |  Clinical News  |  Clinical Status

PLX-PAD cells: Phase II hold

Pluristem said FDA placed a clinical hold on a placebo-controlled, U.S. Phase II trial of PLX-PAD to treat intermittent claudication. The company said there was a severe allergic reaction in a patient that required hospitalization, and that the patient was discharged the...

Read the full 187 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >